Unither Pharmaceuticals
VC Fund
Paris, France
Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories, and generic products. The world leader in the contract manufacturing of pharmaceutical products.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Unither Pharmaceuticals invests in
Stages Unither Pharmaceuticals invests in
Countries Unither Pharmaceuticals invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Corporate Round
- $453k–$963k
Investment Focus
Industry
- Health Care 2 (67%)
- B2B 1 (33%)
- SMS 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
Stage
- Seed 1 (33%)
- Corporate Round 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexandre Rochereau
Chief Information Officer
|
Chief Information Officer | Total investments: 0 | Find email | |
Eric Goupil
CEO
|
CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BIOPHTA
|
BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management. | $7.1M / Seed / Jun 03, 2024 | |
Curecall
|
Curecall is a telecare solution that allows healthcare professionals to follow their patients by SMS in a personalized and automated way. | $963.4K / Corporate Round / Apr 19, 2021 | |
|
Curecall
|
Curecall is a telecare solution that allows healthcare professionals to follow their patients by SMS in a personalized and automated way. | $452.5K / Corporate Round / Jun 23, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Unither Pharmaceuticals invest in?
Unither Pharmaceuticals invests primarily in Health Care, B2B and SMS startups, most often at Seed and Corporate Round stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Unither Pharmaceuticals's check size?
Unither Pharmaceuticals typically joins rounds of $453k–$963k at Corporate Round. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Unither Pharmaceuticals participates in.
How do I contact Unither Pharmaceuticals?
Public channels for Unither Pharmaceuticals include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Unither Pharmaceuticals?
The team at Unither Pharmaceuticals includes Alexandre Rochereau (Chief Information Officer) and Eric Goupil (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
